Falconi J, Strobel K, Djiane A, Lassus P [Drosophila as a model to study cancer biology]. Bull Cancer. 2024;111(9):880-892. doi:10.1016/j.bulcan.2024.05.005
Quénet F, Carrère S, Sgarbura O [Contribution of intraperitoneal chemotherapy in the treatment of colorectal peritoneal carcinoma. HIPEC, PIPAC, state of the art and future directions]. Bull Cancer. 2024;111(3):285-290. doi:10.1016/j.bulcan.2023.10.006
Slaninová V, Heron-Milhavet L, Robin M, Jeanson L, Aissanou A, Kantar D, Tosi D, Bréhélin L, Gongora C, Djiane A The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. BMC Cancer. 2024;24(1):587. doi:10.1186/s12885-024-12316-4
Kawabata-Iwakawa R, Iwasa N, Satoh K, Colinge J, Shimada M, Takeuchi S, Fujiwara H, Eguchi H, Oishi T, Sugiyama T, Suzuki M, Hasegawa K, Fujiwara K, Nishiyama M Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models. Int J Clin Oncol. 2024;29(9):1334-1346. doi:10.1007/s10147-024-02552-w
Esposito F, Sinquin C, Colliec-Jouault S, Cuenot S, Pugnière M, Ngo G, Traboni S, Zykwinska A, Bedini E Multi-step semi-synthesis, structural characterization and growth factor interaction study of regiochemically sulfated diabolican polysaccharides. Int J Biol Macromol. 2024;260(Pt 1):129483. doi:10.1016/j.ijbiomac.2024.129483
Giroux P, Vialaret J, Kindermans J, Gabelle A, Bauchet L, Hirtz C, Lehmann S, Colinge J Modeling the Simultaneous Dynamics of Proteins in Blood Plasma and the Cerebrospinal Fluid in Human In Vivo. J Proteome Res. 2024;23(7):2408-2418. doi:10.1021/acs.jproteome.4c00059
Aubert M, Mege D, Ezzedine W, Pocard M, Quenet F, Wernert R, Glehen O, Pirro N Impact of obesity after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for rare peritoneal malignancies: Paradox of obesity or poor prognostic factor?. Eur J Surg Oncol. 2024;50(9):108507. doi:10.1016/j.ejso.2024.108507
Mairaville C, Broyon M, Maurel M, Chentouf M, Chiavarina B, Turtoi A, Pirot N, Martineau P Identification of monoclonal antibodies from naive antibody phage-display libraries for protein detection in formalin-fixed paraffin-embedded tissues. J Immunol Methods. 2024;532. doi:10.1016/j.jim.2024.113730
Fisher O, Brown C, Esquivel J, Larsen S, Liauw W, Alzahrani N, Morris D, Kepenekian V, Sourrouille I, Tuech J-J, Ceribelli C, Sgarbura O, Alhosni M, Glehen O, Cashin P Hyperthermic intraperitoneal chemotherapy in colorectal cancer. BJS Open. 2024;8(3):zrae017. doi:10.1093/bjsopen/zrae017
Senesse P, Briant J, Boisselier P, Bensadoun R-J, Vinches M, Faravel K Head and neck cancer patients treated with concomitant chemoradiotherapy involving the oral cavity and oropharynx: is another choice possible than prophylactic gastrostomy?. Curr Opin Oncol. 2024;36(3):128-135. doi:10.1097/CCO.0000000000001031
Rigal E, Courot H, Multrier C, Zemiti S, Lambour J, Pugnière M, de Toledo M, Bossis G, Cartron G, Robert B, Martineau P, Fauvel B, Presumey J, Villalba M Generation of non-genetically modified, CAR-like, NK cells. J Immunother Cancer. 2024;12(7):e009070. doi:10.1136/jitc-2024-009070
Rodríguez-Vázquez M, Falconi J, Heron-Milhavet L, Lassus P, Géminard C, Djiane A Fat body glycolysis defects inhibit mTOR and promote distant muscle disorganization through TNF-?/egr and ImpL2 signaling in Drosophila larvae. EMBO Rep. 2024-09-09. doi:10.1038/s44319-024-00241-3
Figarol S, Delahaye C, Gence R, Doussine A, Cerapio J, Brachais M, Tardy C, Béry N, Asslan R, Colinge J, Villemin J-P, Maraver A, Ferrer I, Paz-Ares L, Kessler L, Burrows F, Lajoie-Mazenc I, Dongay V, Morin C, Florent A, Pagano S, Taranchon-Clermont E, Casanova A, Pradines A, Favre G, Calvayrac O Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies. Nat Commun. 2024;15(1):5345. doi:10.1038/s41467-024-49360-4
Lehmann S, Vialaret J, Gabelle A, Bauchet L, Villemin J-P, Hirtz C, Colinge J Enabling population protein dynamics through Bayesian modeling. Bioinformatics. 2024;40(8):btae484. doi:10.1093/bioinformatics/btae484
Trecourt A, Bakrin N, Glehen O, Gertych W, Villeneuve L, Isaac S, Benzerdjeb N, Fontaine J, Genestie C, Dartigues P, Leroux A, Odin C, Khellaf L, Svrcek M, Thierry S, Augros M, Omar A, Devouassoux-Shisheboran M, Kepenekian V Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study. Ann Surg Oncol. 2024;31(5):3325-3338. doi:10.1245/s10434-023-14850-0
Gruel N Cellular origin and clonal evolution of human dedifferentiated liposarcoma. 2024.
Honda C, Kurozumi S, Fujii T, Pourquier D, Khellaf L, Horiguchi J, Oyama T, Shirabe K, Colinge J, Yokobori T, Turtoi A Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-? activity and CD8+ T-cell infiltration in breast cancer. Theranostics. 2024;14(5):1873-1885. doi:10.7150/thno.90627
Riscal R, Gardner S, Coffey N, Carens M, Mesaros C, Xu J, Xue Y, Davis L, Demczyszyn S, Vogt A, Olia A, Finan J, Godfrey J, Schultz D, Blair I, Keith B, Marmorstein R, Skuli N, Simon M Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell Carcinoma. 2024;84(10):1570-1582. doi:10.1158/0008-5472.CAN-23-0821
Trecourt A, Bakrin N, Glehen O, Gertych W, Villeneuve L, Isaac S, Benzerdjeb N, Fontaine J, Genestie C, Dartigues P, Leroux A, Odin C, Khellaf L, Svrcek M, Thierry S, Augros M, Omar A, Devouassoux-Shisheboran M, Kepenekian V ASO Visual Abstract: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study. Ann Surg Oncol. 2024-02-09. doi:10.1245/s10434-024-14925-6
Desroys du Roure P, Lajoie L, Mallavialle A, Alcaraz L, Mansouri H, Fenou L, Garambois V, Rubio L, David T, Coenon L, Boissière-Michot F, Chateau M-C, Ngo G, Jarlier M, Villalba M, Martineau P, Laurent-Matha V, Roger P, Guiu S, Chardès T, Gros L, Liaudet-Coopman E A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. J Immunother Cancer. 2024;12(1):e007135. doi:10.1136/jitc-2023-007135
Roussel-Simonin C, Croce S, Guyon F, Llacer C, Ray-Coquard I, Meeus P, Genestie C, Malhaire C, Duffaud F, Pautier P [Uterin sarcoma, high-grade stroma, indifferenciated, referential]. Bull Cancer. 2023;110(7-8):855-864. doi:10.1016/j.bulcan.2023.03.017
Alexandre M, Jacot W [Therapeutic advances in HER2+ breast cancer]. Rev Prat. 2023;73(4):355-359.
Bourgier C, Boisbouvier S, Bayart É, Chamois J, Clavère P, Corbin S, De Oliveira A, Hannoun-Lévi J-M, Hasbini A, Geffroy-Hulot C, Le Tallec P, Monpetit É, Santini J-J [Radiation therapists shortage in France: Organizational consequences and difficulties in deploying new missions and/or tasks delegation]. Cancer Radiother. 2023;27(6-7):577-582. doi:10.1016/j.canrad.2023.07.007
Quesada S, Solassol J, Ray-Coquard I, Fabbro M [Homologous recombination deficiency in epithelial ovarian cancers: from molecular characterization to patient journey]. Bull Cancer. 2023;110(4):371-381. doi:10.1016/j.bulcan.2023.02.004
Bollet M, Racadot S, Rivera S, Arnaud A, Bourgier C [Breast cancer radiation therapy: Current questions in 2023]. Cancer Radiother. 2023;27(6-7):524-530. doi:10.1016/j.canrad.2023.07.005